(Q36417743)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Mechanisms of disease: angiogenesis in urologic malignancies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Philip J S Charlesworth

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

published in

Nature Reviews Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

157-169

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ncpuro0434

17 January 2020

exact match

0 references

cites work

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

The combination of antiangiogenic and cytotoxic agents in the treatment of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPURO0434

1 reference

7 January 2021

Vascular zip codes in angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Tumorigenesis and the angiogenic switch

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Novel angiogenic signaling pathways and vascular targets

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Hypoxia--a key regulatory factor in tumour growth

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Matrix metalloproteinases and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Endogenous angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Downmodulation of bFGF-binding protein expression following restoration of p53 function

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Clinical translation of angiogenesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Histological quantitation of tumour angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH BLADDER CANCER RECURRENCE RATES

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

The epidermal growth factor receptor and the prognosis of bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Expression of cyclooxygenase-2 in patients with bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Serum levels of endostatin and matrix metalloproteinase-9 associated with high stage and grade primary transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Histopathological analysis of angiogenic factors in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Expression of vascular endothelial growth factor protein in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Changes in circulating dendritic cells and IL-12 in relation to the angiogenic factor VEGF during IL-2 immunotherapy of metastatic renal cell cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Levels of angiogenesis and expression of angiogenesis-related genes are prognostic for organ-specific metastasis of renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Microvessel density in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Molecular markers of prostate cancer outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Serum basic fibroblast growth factor in men with and without prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Angiogenic peptides in prostatic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Macrophages and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Serum interleukin-8 is elevated in men with prostate cancer and bone metastases

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Tissue factor expression and angiogenesis in human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Angiogenesis and prostate cancer tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Recent advances in bladder cancer diagnostics

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Expression of vascular endothelial growth factor in renal cell carcinoma is correlated with cancer advancement

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Angiogenesis and prostate cancer: important laboratory and clinical findings

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Antiangiogenesis therapeutic strategies in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO0434

7 January 2021

Identifiers

DOI

10.1038/NCPURO0434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16528288%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference